High-throughput detection of clinically targetable alterations using next-generation sequencing-Reference-Cited by-同舟云学术

High-throughput detection of clinically targetable alterations using next-generation sequencing

Published:2017-03-03 Issue:25 Volume:8 Page:40345-40358
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Vendrell Julie A.¹,Grand David²,Rouquette Isabelle²,Costes Valérie¹,Icher Samira²,Selves Janick²,Larrieux Marion¹,Barbe Aurore²,Brousset Pierre²³,Solassol Jérôme¹⁴⁵⁶

Affiliation:

1. CHU Montpellier, Arnaud de Villeneuve Hospital, Department of Pathology, Montpellier, France

2. Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, CHU de Toulouse, Toulouse, France

3. Laboratoire d’excellence Labex TOUCAN, Toulouse, France

4. IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France

5. INSERM, Montpellier, France

6. Université de Montpellier, Montpellier, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glyoxal acid-free (GAF) histological fixative is a suitable alternative to formalin: results from an open-label comparative non-inferiority study;Virchows Archiv;2023-11-24

2. Glyoxal Acid-Free (GAF) histological fixative is a suitable alternative to formalin – results from an open label comparative non-inferiority study;2023-05-28

3. Fixation in histopathology: the mandate to renew;Pathologica;2022-09

4. Tissue Fixation with a Formic Acid-Deprived Formalin Better Preserves DNA Integrity over Time;Pathobiology;2022-07-20

5. Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer;Cancers;2021-05-30